INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses On Their Investment In Commvault Systems, Inc. Of Class Action Lawsuit And Upcoming Deadlines CVLT
The class action concerns whether Commvault and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until July 17, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Commvault securities during the Class Period. A copy of the Complaint can be obtained at .
[Click here for information about joining the class action]On January 27, 2026, Commvault reported its financial results for the third quarter of fiscal 2026 and revealed ARR growth below the Company's prior guidance. In particular, ARR growth for the quarter was only $39 million, which fell short of the Company's $45 million guidance.
On this news, Commvault's stock price fell $40.23 per share, or 31.1%, to close at $89.13 per share on January 27, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
...
646-581-9980 ext. 7980
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment